These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 29557182)

  • 21. Genome-Wide DNA Methylation Profiling in Early Stage I Lung Adenocarcinoma Reveals Predictive Aberrant Methylation in the Promoter Region of the Long Noncoding RNA PLUT: An Exploratory Study.
    Kim-Wanner SZ; Assenov Y; Nair MB; Weichenhan D; Benner A; Becker N; Landwehr K; Kuner R; Sültmann H; Esteller M; Koch I; Lindner M; Meister M; Thomas M; Bieg M; Klingmüller U; Schlesner M; Warth A; Brors B; Seifried E; Bönig H; Plass C; Risch A; Muley T
    J Thorac Oncol; 2020 Aug; 15(8):1338-1350. PubMed ID: 32272161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glioblastoma Multiforme: Fewer Tumor Copy Number Segments of the
    Lehrer S; Rheinstein PH; Rosenzweig KE
    Cancer Genomics Proteomics; 2018; 15(4):273-278. PubMed ID: 29976632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentially expressed and survival-related proteins of lung adenocarcinoma with bone metastasis.
    Yang M; Sun Y; Sun J; Wang Z; Zhou Y; Yao G; Gu Y; Zhang H; Zhao H
    Cancer Med; 2018 Apr; 7(4):1081-1092. PubMed ID: 29522283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of highly expressed PAICS in lung adenocarcinoma.
    Zhou S; Yan Y; Chen X; Wang X; Zeng S; Qian L; Wei J; Yang X; Zhou Y; Gong Z; Xu Z
    Gene; 2019 Apr; 692():1-8. PubMed ID: 30641222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long noncoding RNA VPS9D1-AS1 overexpression predicts a poor prognosis in non-small cell lung cancer.
    Tan J; Yang L
    Biomed Pharmacother; 2018 Oct; 106():1600-1606. PubMed ID: 30119235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant NEK2 expression might be an independent predictor for poor recurrence-free survival and overall survival of skin cutaneous melanoma.
    Huang J; Sun SG; Hou S
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3694-3702. PubMed ID: 29949142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MET gene copy number gain is an independent poor prognostic marker in Korean stage I lung adenocarcinomas.
    Jin Y; Sun PL; Kim H; Seo AN; Jheon S; Lee CT; Chung JH
    Ann Surg Oncol; 2014 Feb; 21(2):621-8. PubMed ID: 24212721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
    Zhou S; Wang P; Su X; Chen J; Chen H; Yang H; Fang A; Xie L; Yao Y; Yang J
    PLoS One; 2017; 12(10):e0187356. PubMed ID: 29088286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients.
    Powrózek T; Krawczyk P; Nicoś M; Kuźnar-Kamińska B; Batura-Gabryel H; Milanowski J
    Clin Transl Oncol; 2016 Apr; 18(4):398-404. PubMed ID: 26311076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EGFR gene copy number gain is related to high tumor SUV and frequent relapse after adjuvant chemotherapy in resected lung adenocarcinoma.
    Koh Y; Jang B; Jeon YK; Kim TM; Lee SH; Kim DW; Chung DH; Kim YT; Kim YW; Heo DS
    Jpn J Clin Oncol; 2011 Apr; 41(4):548-54. PubMed ID: 21247966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An analysis about heterogeneity among cancers based on the DNA methylation patterns.
    Liu Y; Gu Y; Su M; Liu H; Zhang S; Zhang Y
    BMC Cancer; 2019 Dec; 19(1):1259. PubMed ID: 31888612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic implication of PTPRH hypomethylation in non-small cell lung cancer.
    Sato T; Soejima K; Arai E; Hamamoto J; Yasuda H; Arai D; Ishioka K; Ohgino K; Naoki K; Kohno T; Tsuta K; Watanabe S; Kanai Y; Betsuyaku T
    Oncol Rep; 2015 Sep; 34(3):1137-45. PubMed ID: 26134684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down-regulation of PAX6 by promoter methylation is associated with poor prognosis in non small cell lung cancer.
    Zhang X; Yang X; Wang J; Liang T; Gu Y; Yang D
    Int J Clin Exp Pathol; 2015; 8(9):11452-7. PubMed ID: 26617874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BUBR1 overexpression predicts disease-specific survival after nephroureterectomy in patients with upper tract urothelial carcinoma.
    Yamamoto Y; Oga A; Akao J; Misumi T; Fuji N; Kobayashi K; Kawai Y; Inoue R; Hirata H; Matsumoto H; Nagao K; Sakano S; Matsuyama H
    Jpn J Clin Oncol; 2016 Aug; 46(8):754-61. PubMed ID: 27174960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High expression of ovarian cancer immunoreactive antigen domain containing 2 (OCIAD2) is associated with poor prognosis in lung adenocarcinoma.
    Sakashita M; Sakashita S; Murata Y; Shiba-Ishii A; Kim Y; Matsuoka R; Nakano N; Sato Y; Noguchi M
    Pathol Int; 2018 Nov; 68(11):596-604. PubMed ID: 30320419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SPC25 upregulation increases cancer stem cell properties in non-small cell lung adenocarcinoma cells and independently predicts poor survival.
    Chen J; Chen H; Yang H; Dai H
    Biomed Pharmacother; 2018 Apr; 100():233-239. PubMed ID: 29432994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Whole genomic copy number variation score: an indicator of potential diagnostic and prognostic value for lung adenocarcinoma].
    Zhang L; He L; Li SL; Du J; Di J; Yang L; Liu CL; Yin LY; Cheng Y; Gong YY; Wu W; Liu DG; Wang Z
    Zhonghua Zhong Liu Za Zhi; 2020 Jul; 42(7):543-550. PubMed ID: 32842440
    [No Abstract]   [Full Text] [Related]  

  • 38. High PITX1 expression in lung adenocarcinoma patients is associated with DNA methylation and poor prognosis.
    Song X; Zhao C; Jiang L; Lin S; Bi J; Wei Q; Yu L; Zhao L; Wei M
    Pathol Res Pract; 2018 Dec; 214(12):2046-2053. PubMed ID: 30322808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased HSPG2 expression independently predicts poor survival in patients with oligoastrocytoma and oligodendroglioma.
    Ma XL; Shang F; Ni W; Zhu J; Luo B; Zhang YQ
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6853-6863. PubMed ID: 30402850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LATS2 as a poor prognostic marker regulates non-small cell lung cancer invasion by modulating MMPs expression.
    Wu A; Li J; Wu K; Mo Y; Luo Y; Ye H; Mai Z; Guo K; Wang Y; Li S; Chen H; Luo W; Yang Z
    Biomed Pharmacother; 2016 Aug; 82():290-7. PubMed ID: 27470365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.